CD274 and neoplasm: In breast and colorectal mouse tumor models, neutralizing antibodies against TGFβ were shown to reduce collagen I production, overcoming the T cell excluded profile and increasing the efficacy of anti-PD-L1 antibodies (Mariathasan et al., 2018; Tauriello et al., 2018).